<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Gutierrez A</submitter><funding>Instituto de Salud Carlos III</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Previous studies comparing immigrant ethnic groups and native patients with IBD have yielded clinical and phenotypic differences. To date, no study has focused on the immigrant IBD population in Spain.&lt;h4>Methods&lt;/h4>Prospective, observational, multicenter study comparing cohorts of IBD patients from ENEIDA-registry who were born outside Spain with a cohort of native patients.&lt;h4>Results&lt;/h4>We included 13,524 patients (1,864 immigrant and 11,660 native). The immigrants were younger (45 ± 12 vs. 54 ± 16 years, &lt;i>p&lt;/i> &lt; 0.001), had been diagnosed younger (31 ± 12 vs. 36 ± 15 years, &lt;i>p&lt;/i> &lt; 0.001), and had a shorter disease duration (14 ± 7 vs. 18 ± 8 years, &lt;i>p&lt;/i> &lt; 0.001) than native patients. Family history of IBD (9 vs. 14%, &lt;i>p&lt;/i> &lt; 0.001) and smoking (30 vs.</pubmed_abstract><journal>Frontiers in medicine</journal><pagination>823900</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8844561</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients.</pubmed_title><pmcid>PMC8844561</pmcid><pubmed_authors>Huguet J</pubmed_authors><pubmed_authors>Fernandez-Salazar L</pubmed_authors><pubmed_authors>Almela P</pubmed_authors><pubmed_authors>Bujanda L</pubmed_authors><pubmed_authors>Varela P</pubmed_authors><pubmed_authors>Carpio D</pubmed_authors><pubmed_authors>Sainz E</pubmed_authors><pubmed_authors>Calvet X</pubmed_authors><pubmed_authors>Merino O</pubmed_authors><pubmed_authors>Manosa M</pubmed_authors><pubmed_authors>Sese E</pubmed_authors><pubmed_authors>Munoz-Villafranca C</pubmed_authors><pubmed_authors>Olivares D</pubmed_authors><pubmed_authors>Domenech E</pubmed_authors><pubmed_authors>Roldon M</pubmed_authors><pubmed_authors>Aguas M</pubmed_authors><pubmed_authors>Morales V</pubmed_authors><pubmed_authors>Perez-Calle JL</pubmed_authors><pubmed_authors>Iglesias E</pubmed_authors><pubmed_authors>Gutierrez A</pubmed_authors><pubmed_authors>Ginard D</pubmed_authors><pubmed_authors>Zapater P</pubmed_authors><pubmed_authors>Munoz R</pubmed_authors><pubmed_authors>Van Domselaar M</pubmed_authors><pubmed_authors>Busquets D</pubmed_authors><pubmed_authors>Arguelles-Arias F</pubmed_authors><pubmed_authors>Alcain G</pubmed_authors><pubmed_authors>Bermejo F</pubmed_authors><pubmed_authors>Vela M</pubmed_authors><pubmed_authors>Riera J</pubmed_authors><pubmed_authors>Martinez-Montiel MP</pubmed_authors><pubmed_authors>Piqueras M</pubmed_authors><pubmed_authors>Bosca-Watts M</pubmed_authors><pubmed_authors>Gisbert JP</pubmed_authors><pubmed_authors>Madero L</pubmed_authors><pubmed_authors>De Francisco R</pubmed_authors><pubmed_authors>Rodriguez C</pubmed_authors><pubmed_authors>Mancenido N</pubmed_authors><pubmed_authors>Roncero O</pubmed_authors><pubmed_authors>Martin-Arranz MD</pubmed_authors><pubmed_authors>Navarro M</pubmed_authors><pubmed_authors>Sanchez-Rodriguez E</pubmed_authors><pubmed_authors>Laredo V</pubmed_authors><pubmed_authors>Ricart E</pubmed_authors><pubmed_authors>Gonzalez-Vivo M</pubmed_authors><pubmed_authors>Herreros B</pubmed_authors><pubmed_authors>Zabana Y</pubmed_authors><pubmed_authors>Frances R</pubmed_authors><pubmed_authors>Gordillo J</pubmed_authors><pubmed_authors>Hinojosa E</pubmed_authors><pubmed_authors>Lucendo AJ</pubmed_authors><pubmed_authors>Munoz F</pubmed_authors><pubmed_authors>Rivero M</pubmed_authors><pubmed_authors>De Castro L</pubmed_authors><pubmed_authors>Vera I</pubmed_authors><pubmed_authors>Arias L</pubmed_authors><pubmed_authors>Barrio J</pubmed_authors><pubmed_authors>Marin-Jimenez I</pubmed_authors><pubmed_authors>Camps B</pubmed_authors><pubmed_authors>Lorente R</pubmed_authors><pubmed_authors>Barreiro-de Acosta M</pubmed_authors><pubmed_authors>Sierra E</pubmed_authors><pubmed_authors>Ramos L</pubmed_authors><pubmed_authors>Sierra M</pubmed_authors><pubmed_authors>Rodriguez-Lago I</pubmed_authors><pubmed_authors>Sempere L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients.</name><description>&lt;h4>Background&lt;/h4>Previous studies comparing immigrant ethnic groups and native patients with IBD have yielded clinical and phenotypic differences. To date, no study has focused on the immigrant IBD population in Spain.&lt;h4>Methods&lt;/h4>Prospective, observational, multicenter study comparing cohorts of IBD patients from ENEIDA-registry who were born outside Spain with a cohort of native patients.&lt;h4>Results&lt;/h4>We included 13,524 patients (1,864 immigrant and 11,660 native). The immigrants were younger (45 ± 12 vs. 54 ± 16 years, &lt;i>p&lt;/i> &lt; 0.001), had been diagnosed younger (31 ± 12 vs. 36 ± 15 years, &lt;i>p&lt;/i> &lt; 0.001), and had a shorter disease duration (14 ± 7 vs. 18 ± 8 years, &lt;i>p&lt;/i> &lt; 0.001) than native patients. Family history of IBD (9 vs. 14%, &lt;i>p&lt;/i> &lt; 0.001) and smoking (30 vs.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2026-03-27T16:43:22.591Z</modification><creation>2025-04-04T08:58:21.551Z</creation></dates><accession>S-EPMC8844561</accession><cross_references><pubmed>35178413</pubmed><doi>10.3389/fmed.2022.823900</doi></cross_references></HashMap>